Background: |
STK40 (Serine/threonine-protein kinase 40), also known as Sugen kinase 495, is a 435 amino acid protein kinase that may be a negative regulator of NFκB and p53-mediated gene expression. Localized to both the cytoplasm and the nucleus, STK40 is ubiquitously expressed. STK40 has a central serine/threonine protein kinase domain and is homologous to TRB-3, a protein that regulates activation of MAP kinases and inhibits NFκB-mediated gene transcription. |
Applications: |
ELISA, WB, IHC |
Name of antibody: |
STK40 |
Immunogen: |
Fusion protein of human STK40 |
Full name: |
serine/threonine kinase 40 |
Synonyms: |
SHIK; SgK495 |
SwissProt: |
Q8N2I9 |
ELISA Recommended dilution: |
1000-2000 |
IHC positive control: |
Human cervical cancer and human thyroid cancer |
IHC Recommend dilution: |
50-200 |
WB Predicted band size: |
49 kDa |
WB Positive control: |
Human placenta tissue |
WB Recommended dilution: |
200-1000 |